Kathleen M C Sullivan

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 07, 2023
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.

Kathleen M C Sullivan, Marta Vilalta, Linda S Ertl

Pageof 1

Frequent Collaborators